Singapore's first commercial developer of molecular diagnostic assays opens operations
03-Sep-2008
- Singapore
Dx Assays is a joint venture between Qiagen and Bio*One Capital, the dedicated biomedical science investment company of EDB Investments.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.